Establishing and expressing method for chimeric vector of EV71 neutralization epitope and norovirus P structure domain
An antigenic epitope, EV71 technology, applied in the field of genetic engineering, can solve the problems of complex production process and high production cost, and achieve the effects of simple preparation and simple purification process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0045] (1) Construction and identification of recombinant plasmids
[0046] Plasmid P42 is from Cincinnati Children's Medical Research Center, USA (patent protected, patent number: WO2010144602-A2; US2010322962-A1; WO2010144602-A3; EP2440582-A2; CN102612525-A; JP2012529298-W; HK1169426-A4; US841 ; US2013273090), it is a vector containing the GST tag and human norovirus GII.4 genotype P domain (GI: 146387016) gene, the plasmid map see figure 1 . The amino acid sequences of the neutralizing antigenic epitopes of EV71 were obtained from literature reports, namely the SP55 (163aa-177aa) and SP70 (208aa-222aa) on VP1 and the SP28 (136-150aa) epitopes on VP2 ( figure 2 ), optimize the nucleotide sequence of each single epitope according to the preference of Escherichia coli codon expression, and design the tandem epitope composed of single epitope combination: SP55-SP70-SP28, SP55-SP70, SP55-SP28, SP70-SP28 (the nucleotide sequences are respectively shown in SEQ ID NO: 2 to SEQ I...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com